top of page
"Enabling patients to take control of sampling"
PCSIG-WhoWeAre.jpg

Vision

The Patient Centric Sampling Interest Group (PCSIG) is a not for profit Community Interest Company, incorporated in the UK. It is a global collaborative collective of individuals and organizations who have a shared interest in promoting patient centric sampling approaches. They are unified by their interest in facilitating the development and implementation of novel sample collection technologies for integration into standard of care.

The group is focused on fostering a broader understanding and future widespread implementation of these technologies and serves as a clearing-house for information that helps support this cause. Furthermore, the group’s aim is to become the industry catalyst for innovation, technology transfer and the sharing of best practice between members, leading to better outcomes for these organizations and the end consumers of the technologies developed. This will be accomplished as a collaborative association, which is free to join for individuals and is funded by sponsorship.

Scope

  • Actively engage with stakeholders, including patients, healthcare providers, regulators, scientific experts, technology providers and policy makers to understand and address their concerns surrounding patient centric sampling and analysis.

​​

  • Act as a platform for collaborative activities associated with the development and implementation of patient centric sampling and analysis technologies for the provision of high quality information for decision making by stakeholders.

​​

  • Act as a focal point for enquiries from stakeholders on patient centric sampling and related technologies.

​​

  • Provide a framework for maintaining the highest standards of ethics, data integrity, scientific quality, compliance and transparency in the interest group’s activities.

​​

  • Is free to join and is open to all that are interested in furthering its remit and no bias is shown to any particular organization or technology.

 

  • Company proprietary intellectual property will not be shared, unless publicly available.

​​

  • Any promotional activities associated with the marketing and pricing of patient centric blood sampling and analysis technologies by the interest group members is outside the scope of this interest group.

bottom of page